Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02394197Phase 4Completed
Phase 4, randomised, open-label trial of chloroquine and primaquine in Plasmodium vivax malaria (2 arms). Primary endpoints: Changes in the presence and density of asexual parasites at 12 months, Changes in the presence and severity of clinical symptoms at 12 months and 1 more. Started Feb 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02394197.